FIELD: medicine.
SUBSTANCE: group of inventions relates to methods of treating systemic juvenile idiopathic arthritis with a polyarticular course using an antibody which specifically binds the human interleukin-6 receptor (IL-6R). Antibody is administered subcutaneously in dose of 2 to 4 mg/kg once a week or once every two weeks. Subject may be between 2 and 17 years old.
EFFECT: invention provides effective and safe methods of treating persistent types of JIA.
16 cl, 11 tbl, 33 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS FOR RHEUMATOID ARTHRITIS TREATMENT AND METHODS OF THEIR APPLICATION | 2012 |
|
RU2664697C2 |
| COMPOSITIONS CONTAINING ANTIBODIES TO IL6R FOR TREATMENT OF UVEITIS AND MACULAR EDEMA AND METHODS OF THEIR USE | 2016 |
|
RU2747193C2 |
| METHOD OF TREATMENT OF ATOPIC DERMATITIS THROUGH INTRODUCTION OF IL-4R INHIBITOR | 2019 |
|
RU2801204C2 |
| METHODS OF TREATING OR PREVENTING ASTHMA BY ADMINISTERING IL-4R ANTAGONIST | 2015 |
|
RU2713406C2 |
| METHODS OF TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH) | 2015 |
|
RU2735521C2 |
| GM-CSF-NEUTRALIZING ANTIBODIES FOR USE IN TREATING RHEUMATOID ARTHRITIS OR AS ANALGESICS | 2014 |
|
RU2714919C2 |
| ANTIBODIES TO B7-H1 AND CTLA-4 FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER | 2015 |
|
RU2806210C2 |
| ANTIBODIES TO FGFR2 IN COMBINATION WITH CHEMOTHERAPY IN CANCER TREATMENT | 2018 |
|
RU2797560C2 |
| METHODS OF TREATING PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR DISEASES HAVING HYPERCHOLESTEROLEMIA | 2015 |
|
RU2723018C2 |
| ANTIBODIES TO CD40 FOR USE IN THE TREATMENT OF SJOGREN'S SYNDROME | 2018 |
|
RU2790558C2 |
